Comparative Testing of Various Pancreatic Cancer Stem Cells Results in a Novel Class of Pancreatic-Cancer–Initiating Cells

No systemic therapy is effective against pancreatic cancer (PC). Pancreatic cancer stem cells (PCSC) are hypothesized to account for therapeutic resistance. Several PCSC subpopulations were reported, each characterized by different markers. To be able to target PCSC, we sought to better define this...

Full description

Saved in:
Bibliographic Details
Main Authors: Jaiswal, Kshama R., Xin, Hong-Wu, Anderson, Andrew, Wiegand, Gordon, Kim, Bo, Miller, Tyler, Hari, Danielle, Ray, Satyajit, Koizumi, Tomotake, Rudloff, Udo, Thorgeirsson, Snorri S., Avital, Itzhak
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490042/
https://ncbi.nlm.nih.gov/pubmed/22963768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.scr.2012.08.001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items